116293-90-4 Usage
General Description
6-Fluoroquinoline-3-carboxylic acid is a chemical compound with the molecular formula C10H6FNO2. It is a quinoline derivative containing a carboxylic acid group and a fluorine atom. 6-FLUOROQUINOLINE-3-CARBOXYLIC ACID is often used as a building block in the synthesis of pharmaceuticals and agrochemicals due to its ability to form a wide range of derivatives with varied biological activities. It has been studied for its potential antitumor, antimicrobial, and antiviral properties. Additionally, 6-fluoroquinoline-3-carboxylic acid has been investigated for its potential as a fluorescent probe for the detection of reactive oxygen species in biological systems.
Check Digit Verification of cas no
The CAS Registry Mumber 116293-90-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,2,9 and 3 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 116293-90:
(8*1)+(7*1)+(6*6)+(5*2)+(4*9)+(3*3)+(2*9)+(1*0)=124
124 % 10 = 4
So 116293-90-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H6FNO2/c11-8-1-2-9-6(4-8)3-7(5-12-9)10(13)14/h1-5H,(H,13,14)
116293-90-4Relevant articles and documents
P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS
-
Paragraph 0252-0255, (2018/04/17)
The present disclosure provides novel compounds and methods for preparing and using these compounds. In one embodiment, the compounds are of the structure of formula (I), wherein R1-R7 are defined herein. In a further embodiment, these compounds are useful in method for regulating one or both of the P2X3 or P2X2/3 receptors. In another embodiment, these compounds are useful for treating pain in patients by administering one or more of the compounds to a patient. In another embodiment, these compounds are useful for treating respiratory dysfunction in patients by administering one or more of the compounds to a patient.
TRIAZOLE COMPOUNDS AS LIPOXYGENASE INHIBITORS
-
Page/Page column 46, (2008/06/13)
There is provided compounds of formula (I) wherein W is an optionally substituted aryl or heteroaryl group, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15- lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.
